Immunic, Inc. (IMUX)
11.42
-0.42
(-3.55%)
USD |
NASDAQ |
Sep 11, 16:00
11.39
-0.03
(-0.26%)
After-Hours: 20:00
Immunic Enterprise Value : 1.289M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.289M |
| September 10, 2026 | 7.020M |
| September 09, 2026 | 11.80M |
| September 08, 2026 | 19.30M |
| September 04, 2026 | 24.35M |
| September 03, 2026 | 19.57M |
| September 02, 2026 | 39.77M |
| September 01, 2026 | 44.41M |
| August 31, 2026 | 61.05M |
| August 28, 2026 | 55.59M |
| August 27, 2026 | 67.87M |
| August 26, 2026 | 70.47M |
| August 25, 2026 | 69.51M |
| August 24, 2026 | 70.06M |
| August 21, 2026 | 70.60M |
| August 20, 2026 | 65.15M |
| August 19, 2026 | 69.92M |
| August 18, 2026 | 76.06M |
| August 17, 2026 | 64.19M |
| August 14, 2026 | 64.60M |
| August 13, 2026 | 71.69M |
| August 12, 2026 | 62.83M |
| August 11, 2026 | 56.69M |
| August 10, 2026 | 37.86M |
| August 07, 2026 | 40.59M |
| Date | Value |
|---|---|
| August 06, 2026 | 43.86M |
| August 05, 2026 | 36.63M |
| August 04, 2026 | 37.17M |
| August 03, 2026 | 37.86M |
| July 31, 2026 | 36.08M |
| July 30, 2026 | 36.36M |
| July 29, 2026 | 23.53M |
| July 28, 2026 | 27.49M |
| July 27, 2026 | 33.90M |
| July 24, 2026 | 28.17M |
| July 23, 2026 | 40.31M |
| July 22, 2026 | 51.64M |
| July 21, 2026 | 52.18M |
| July 20, 2026 | 50.14M |
| July 17, 2026 | 52.32M |
| July 16, 2026 | 50.55M |
| July 15, 2026 | 51.50M |
| July 14, 2026 | 45.91M |
| July 13, 2026 | 45.22M |
| July 10, 2026 | 47.00M |
| July 09, 2026 | 47.13M |
| July 08, 2026 | 47.00M |
| July 07, 2026 | 55.05M |
| July 06, 2026 | 48.23M |
| July 02, 2026 | 47.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.908B |
| Sionna Therapeutics, Inc. | 151.58M |
| Alnylam Pharmaceuticals, Inc. | 32.94B |
| Anika Therapeutics, Inc. | 266.01M |
| Savara, Inc. | 945.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -34.10M |
| Total Expenses (Quarterly) | 34.10M |
| EPS Diluted (Quarterly) | -0.8021 |
| Earnings Yield | -42.08% |
| Normalized Earnings Yield | -42.08 |